Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 1;17(13):4477-85.
doi: 10.1016/j.bmc.2009.05.010. Epub 2009 May 8.

QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum

Affiliations

QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum

Fang Zheng et al. Bioorg Med Chem. .

Abstract

Maximal inhibition (I(max)) of the agonist effect is an important pharmacological property of inhibitors that interact with multiple receptor subtypes that are activated by the same agonist and which elicit the same functional response. This report represents the first QSAR study on a set of 66 mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating nicotine-evoked dopamine release, conducted using multi-linear regression (MLR) and neural network (NN) analysis with the maximal inhibition (I(max)) values of the antagonists as target values. The statistical results for the generated MLR model were: r(2)=0.89, rmsd=9.01, q(2)=0.83 and loormsd=11.1; the statistical results for the generated NN model were: r(2)=0.89, rmsd=8.98, q(2)=0.83 and loormsd=11.2. The maximal inhibition values of the compounds exhibited a good correlation with the predictions made by the QSAR models developed, which provide a basis for rationalizing selection of compounds for synthesis in the discovery of effective and selective second generation inhibitors of nAChRs mediating nicotine-evoked dopamine release.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The calculated versus the experimentally determined Imax values from the DA release assay for the trained (shown in blue squares) and leave-one-out cross-validation (shown in red triangles) for the best MLR QSAR model. The solid line represents a perfect correlation. The dotted lines represent ±20% difference from a perfect fit.
Figure 2
Figure 2
The training and leave-one-out errors (rmsd and loormsd) as functions of the number of training cycles of the NN11-1-1, NN11-2-1 and NN11-3-1 models.
Figure 3
Figure 3
The calculated versus the experimentally determined Imax values from the DA release assay for the trained (shown in blue squares) and leave-one-out cross-validation (shown in red triangles) for the NN11-1-1 QSAR model. The solid line represents a perfect correlation. The dotted lines represent ±20% difference from a perfect fit.

Similar articles

Cited by

References

    1. Ericon N. US Department of Justice. 2001 May;17
    1. Lam CY, Minnix JA, Robinson JD, Cinciripini PM. J Natl Compr Canc Netw. 2006;4:583. - PubMed
    1. Glover ED, Rath JM. Expert Opin Pharmacother. 2007;8:1757. - PubMed
    1. Potts LA, Garwood CL. Am J Health-Syst Pharm. 2007;64:1381. - PubMed
    1. Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. N Eng J Med. 1997;337:1195. - PubMed
    2. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto JL, Daughton DM, Doan K, Fiore MC, Baker TBA. N Eng J Med. 1999;340:685. - PubMed
    3. Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G. DeVeaugh-Geiss Psychopharmacol (Berl) 2000;148:33. - PubMed
    4. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV. Clin Pharmacol Ther. 1994;56:86. - PubMed
    5. Rose JE, Westman EC, Behm FM, Johnson MP, Goldberg JS. Pharmacol Biochem Behav. 1999;62:165. - PubMed

Publication types

MeSH terms

LinkOut - more resources